China SXT Pharmaceuticals Inc
SXTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.6M
Close$
$6.88
210% upside
Current Fair Value
210% upsideUndervalued by 210% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.60 Million |
|---|---|
| Enterprise Value | $-25,348,899.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.13 |
| Beta | 1.9 |
| Outstanding Shares | 585,774 |
Return
| Return on Equity | -24.82% |
|---|---|
| Return on Assets | -21.22% |
| Return on Invested Capital | -28.07% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | 0.31 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 0.04 |
| Enterprise Value to Revenue | -9.99 |
| Enterprise Value to EBIT | 2.97 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.17%▲ 0.17% |
|---|---|
| Total Invested | $131,330 |
| Investors Holding | 3▲ 3.00% |
ESG Score
No data